Toth Financial Advisory’s 20/20 Biolabs Inc AIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55 Sell
100
-57
-36% -$72 ﹤0.01% 873
2026
Q1
$296 Buy
+157
New +$663 ﹤0.01% 861

Other funds holding AIDX

Toth Financial Advisory's AIDX Position: Q2 2026 in Review

Toth Financial Advisory reduced its 20/20 Biolabs Inc (AIDX) stake by 36% in Q2 2026, selling an estimated $72 and leaving 100 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Toth Financial Advisory first reported a position in AIDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $296 in Q1 2026. 3 funds tracked by Wall St. Rank hold AIDX as of Q2 2026.

  • Toth Financial Advisory held 100 shares of 20/20 Biolabs Inc worth $55 as of Q2 2026.
  • Toth Financial Advisory sold 57 20/20 Biolabs Inc shares in Q2 2026, an estimated $72.
  • 20/20 Biolabs Inc made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #873 holding.
  • Toth Financial Advisory first reported a position in 20/20 Biolabs Inc in Q1 2026 and has held it in 2 quarters since.
  • Toth Financial Advisory's 20/20 Biolabs Inc position peaked at $296 in Q1 2026.
  • 3 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.